Published in
Elsevier, Annals of Oncology, (32), p. S725, 2021
DOI: 10.1016/j.annonc.2021.08.1164
Links
Tools
721O Relacorilant, a selective glucocorticoid receptor modulator, in combination with nab-paclitaxel improves progression-free survival in patients with recurrent platinum-resistant ovarian cancer: A 3-arm, randomized, open-label, phase II study
Journal article published in 2021 by
N. Colombo,
D. D. Nguyen,
G. F. Fleming,
R. N. Grisham,
D. Lorusso,
T. Van Gorp 
,
A. Oaknin,
H. I. Pashova,
A. Grauer
,
A. Oaknin,
H. I. Pashova,
A. Grauer
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 